Retrospective Study
Copyright ©The Author(s) 2017.
World J Gastrointest Oncol. Aug 15, 2017; 9(8): 319-326
Published online Aug 15, 2017. doi: 10.4251/wjgo.v9.i8.319
Table 2 Clinical characteristics of 240 patients and tumor characteristics in 265 specimens n (%)
VariablesDiscrepancyNon-discrepancyP value
Age (n = 240)
Median, yr (range)58 (31-83)61 (35-90)0.073
Sex (n = 240)
Male17 (70.8)147 (68.1)0.781
Female7 (29.2)69 (31.9)
Underlying disease1 (n = 240)
Yes12 (50.0)100 (46.3)0.730
No12 (50.0)116 (53.7)
Location (n = 265)
Upper4 (16.0)17 (7.1)0.776
Middle10 (40.0)130 (54.2)
Lower11 (44.0)93 (38.8)
Gross pattern (n = 265)
Elevated1 (4.0)22 (9.2)0.668
Flat5 (20.0)42 (17.5)
Depressed10 (40.0)93 (38.8)
Mixed elevated2 (8.0)24 (10.0)
Mixed flat4 (16.0)31 (12.9)
Mixed depressed3 (12.0)28 (11.7)
Ulcer (n = 265)
Positive12 (48.0)100 (41.7)0.542
Negative13 (52.0)140 (58.3)
Erythema (n = 265)
Positive5 (20.0)52 (21.7)0.847
Negative20 (80.0)188 (78.3)
Fold change (n = 265)
Positive20 (80.0)109 (45.4)0.001
Negative5 (20.0)131 (54.9)
Easy friability (n = 265)
Positive9 (36.0)84 (35.0)0.921
Negative16 (64.0)156 (65.0)
Exudate (n = 265)
Positive5 (20.0)36 (15.0)0.511
Negative20 (80.0)204 (85.0)
Number of biopsies (n = 265)
Median (range)3 (2-6)3 (1-10)0.332
Follow-up period (mo) (n = 240)
Median (range)41 (2-72)36 (2-76)0.629
Recurrences during follow-up (n = 240)1 (4.2)2 (0.9)0.272
Death during follow-up (n = 240)0 (0.0)4 (1.9)1.000